Peptide-Conjugated PMOs for the Treatment of Myotonic Dystrophy. (2023)
Attributed to:
Preclinical Development of Peptide Oligonucleotides for Myotonic Dystrophy Type 1
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/978-1-0716-2772-3_13
PubMed Identifier: 36401033
Publication URI: http://europepmc.org/abstract/MED/36401033
Type: Journal Article/Review
Volume: 2587
Parent Publication: Methods in molecular biology (Clifton, N.J.)
ISSN: 1064-3745